Puneet Souda
Stock Analyst at Leerink Partners
(4.12)
# 1,658
Out of 5,128 analysts
934
Total ratings
45.4%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Reiterated: Buy | $190 → $175 | $114.22 | +53.21% | 35 | Nov 13, 2026 | |
| BRKR Bruker | Reiterated: Buy | $80 → $85 | $60.33 | +40.89% | 51 | Nov 5, 2026 | |
| RVTY Revvity | Reiterated: Buy | $180 | $157.02 | +14.64% | 16 | Nov 5, 2026 | |
| VCYT Veracyte | Downgraded: Hold | $45 → $35 | $24.63 | +42.10% | 41 | Nov 5, 2026 | |
| NEO NeoGenomics | Reiterated: Buy | $25 → $35 | $16.54 | +111.61% | 51 | Oct 29, 2026 | |
| ILMN Illumina | Reiterated: Buy | $210 → $300 | $209.55 | +43.16% | 83 | Sep 29, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $40 → $90 | $59.10 | +52.28% | 13 | Sep 29, 2026 | |
| SVRN SVRN, Inc. | Reiterated: Buy | n/a | $15.23 | - | 2 | Sep 17, 2026 | |
| NTRA Natera | Reiterated: Buy | $330 | $322.94 | +2.19% | 66 | Aug 7, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | $73 | $72.84 | +0.22% | 44 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $154.86 | - | 67 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $31.76 | +10.20% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 → $580 | $699.44 | n/a | 50 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $235 | $232.16 | n/a | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $166.52 | n/a | 42 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $2.86 | n/a | 60 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $173.01 | n/a | 39 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.95 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $16 | $20.10 | n/a | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 → $12 | $9.79 | n/a | 40 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $5.68 | n/a | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $34.50 | n/a | 48 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $462.20 | n/a | 38 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.05 | n/a | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.03 | n/a | 1 | Jun 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $11.62 | n/a | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.16 | n/a | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.60 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $22.05 | n/a | 1 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.000001 | n/a | 7 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.009 | n/a | 9 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $25.74 | n/a | 1 | Oct 20, 2014 |
Twist Bioscience
Nov 13, 2026
Reiterated: Buy
Price Target: $190 → $175
Current: $114.22
Upside: +53.21%
Bruker
Nov 5, 2026
Reiterated: Buy
Price Target: $80 → $85
Current: $60.33
Upside: +40.89%
Revvity
Nov 5, 2026
Reiterated: Buy
Price Target: $180
Current: $157.02
Upside: +14.64%
Veracyte
Nov 5, 2026
Downgraded: Hold
Price Target: $45 → $35
Current: $24.63
Upside: +42.10%
NeoGenomics
Oct 29, 2026
Reiterated: Buy
Price Target: $25 → $35
Current: $16.54
Upside: +111.61%
Illumina
Sep 29, 2026
Reiterated: Buy
Price Target: $210 → $300
Current: $209.55
Upside: +43.16%
10x Genomics
Sep 29, 2026
Reiterated: Hold
Price Target: $40 → $90
Current: $59.10
Upside: +52.28%
SVRN, Inc.
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.23
Upside: -
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $330
Current: $322.94
Upside: +2.19%
Bio-Techne
Jun 25, 2026
Downgraded: Hold
Price Target: $73
Current: $72.84
Upside: +0.22%
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $154.86
Upside: -
May 12, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $31.76
Upside: +10.20%
Oct 23, 2025
Reiterated: Buy
Price Target: $500 → $580
Current: $699.44
Upside: n/a
Oct 22, 2025
Reiterated: Buy
Price Target: $235
Current: $232.16
Upside: n/a
Sep 11, 2025
Reiterated: Buy
Price Target: $200
Current: $166.52
Upside: n/a
Sep 10, 2025
Reiterated: Hold
Price Target: $6
Current: $2.86
Upside: n/a
Sep 1, 2025
Reiterated: Buy
Price Target: $140
Current: $173.01
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $4.95
Upside: n/a
Aug 6, 2025
Upgraded: Buy
Price Target: $10 → $16
Current: $20.10
Upside: n/a
Aug 6, 2025
Upgraded: Buy
Price Target: $7 → $12
Current: $9.79
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $9
Current: $5.68
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $35
Current: $34.50
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $340
Current: $462.20
Upside: n/a
Jul 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.05
Upside: n/a
Jun 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.03
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $5
Current: $11.62
Upside: n/a
May 7, 2024
Reiterated: Buy
Price Target: n/a
Current: $33.16
Upside: n/a
Dec 19, 2023
Reiterated: Buy
Price Target: n/a
Current: $33.60
Upside: n/a
Apr 29, 2022
Reiterated: Buy
Price Target: $16
Current: $22.05
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $3
Current: $0.009
Upside: n/a
Oct 20, 2014
Reiterated: Buy
Price Target: $80
Current: $25.74
Upside: n/a